AI assistant
Sending…
Gossamer Bio, Inc. — Director's Dealing 2020
Jan 2, 2020
32603_dirs_2020-01-02_771c51a5-26ec-472e-b29f-48b77008a46c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2019-12-31
Reporting Person: Salter-Cid Luisa (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | Common Stock | G | 4000 | $0.00 | Disposed | 120056 | Direct |
More from Gossamer Bio, Inc.
Regulatory Filings
2026
Jun 2
Proxy Solicitation & Information Statement
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 24
Director's Dealing
2026
Mar 20